These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Comparison of saftey and immunogenicity of purified chick embryo cell rabies vaccine (PCECV) and purified vero cell rabies vaccine (PVRV) using the Thai Red Cross intradermal regimen at a dose of 0.1 ML. Madhusudana SN; Sanjay TV; Mahendra BJ; Sudarshan MK; Narayana DH; Giri A; Muhamuda K; Ravi V; Vakil HB; Malerczyk C Hum Vaccin; 2006; 2(5):200-4. PubMed ID: 17035734 [TBL] [Abstract][Full Text] [Related]
5. A comparative study on the safety and immunogenicity of Purified duck embryo vaccine [corrected] (PDEV, Vaxirab) with purified chick embryo cell vaccine (PCEC, Rabipur) and purifed vero cell rabies vaccine (PVRV, Verorab). Ashwathnarayana DH; Madhusudana SN; Sampath G; Sathpathy DM; Mankeshwar R; Ravish HH; Ullas PT; Behra TR; Sudarshan MK; Gangaboraiah ; Shamanna M Vaccine; 2009 Dec; 28(1):148-51. PubMed ID: 19818720 [TBL] [Abstract][Full Text] [Related]
6. A randomized open-labeled study to demonstrate the non-inferiority of purified chick-embryo cell rabies vaccine administered in the Zagreb regimen (2-1-1) compared with the Essen regimen in Chinese adults. Ma J; Wang H; Li J; Chang L; Xie Y; Liu Z; Zhao Y; Malerczyk C Hum Vaccin Immunother; 2014; 10(10):2805-12. PubMed ID: 25483635 [TBL] [Abstract][Full Text] [Related]
7. Simulated post-exposure rabies vaccination with purified chick embryo cell vaccine using a modified Thai Red Cross regimen. Madhusudana SN; Sanjay TV; Mahendra BJ; Suja MS Int J Infect Dis; 2004 May; 8(3):175-9. PubMed ID: 15109593 [TBL] [Abstract][Full Text] [Related]
8. Comparison of safety and immunogenicity of 2 WHO prequalified rabies vaccines administered by one week, 4 site intra dermal regimen (4-4-4-0-0) in animal bite cases. Narayana A; Manoharan A; Narayan MS; Kalappa SM; Biligumba G; Haradanahalli R; Anand AM Hum Vaccin Immunother; 2015; 11(7):1748-53. PubMed ID: 26083005 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of two intradermal vaccination regimens using purified chick embryo cell vaccine for post-exposure prophylaxis of rabies. Madhusudana SN; Anand NP; Shamsundar R Natl Med J India; 2001; 14(3):145-7. PubMed ID: 11467142 [TBL] [Abstract][Full Text] [Related]
10. Comparative evaluation of immunogenicity, reactogenecity and safety of purified chick embryo cell rabies vaccine and neural tissue rabies vaccine. Deshpande AK; Londhe VA; Akarte S; Briggs D J Assoc Physicians India; 2003 Jul; 51():655-8. PubMed ID: 14621031 [TBL] [Abstract][Full Text] [Related]
11. Safety and immunogenicity of the intradermal Thai red cross (2-2-2-0-1-1) post exposure vaccination regimen in the Indian population using purified chick embryo cell rabies vaccine. Chhabra M; Ichhpujani RL; Bhardwaj M; Tiwari KN; Panda RC; Lal S Indian J Med Microbiol; 2005 Jan; 23(1):24-8. PubMed ID: 15928417 [TBL] [Abstract][Full Text] [Related]
12. Safety and Immunogenicity of purified chick embryo cell rabies vaccine (VaxiRab N) administered intradermally as post exposure prophylaxis. Ravish HS; Vijayashankar V; Madhusudana SN; Sudarshan MK; Narayana DH; Andanaiah G; Ashwin BY; Rachana AR; Shamanna M Hum Vaccin Immunother; 2014; 10(8):2433-7. PubMed ID: 25424951 [TBL] [Abstract][Full Text] [Related]
13. Antibody response of patients after postexposure rabies vaccination with small intradermal doses of purified chick embryo cell vaccine or purified Vero cell rabies vaccine. Briggs DJ; Banzhoff A; Nicolay U; Sirikwin S; Dumavibhat B; Tongswas S; Wasi C Bull World Health Organ; 2000; 78(5):693-8. PubMed ID: 10859864 [TBL] [Abstract][Full Text] [Related]
14. A 1-week intradermal dose-sparing regimen for rabies post-exposure prophylaxis (RESIST-2): an observational cohort study. Cantaert T; Borand L; Kergoat L; Leng C; Ung S; In S; Peng Y; Phoeun C; Hing C; Taing CN; Saman M; Ong S; Mey C; Choeung R; Ly S; Dussart P; Bourhy H; Tarantola A Lancet Infect Dis; 2019 Dec; 19(12):1355-1362. PubMed ID: 31570311 [TBL] [Abstract][Full Text] [Related]
15. Shortening intradermal rabies post-exposure prophylaxis regimens to 1 week: Results from a phase III clinical trial in children, adolescents and adults. Kerdpanich P; Chanthavanich P; De Los Reyes MR; Lim J; Yu D; Ama MC; Mojares Z; Casula D; Arora AK; Pellegrini M PLoS Negl Trop Dis; 2018 Jun; 12(6):e0006340. PubMed ID: 29874228 [TBL] [Abstract][Full Text] [Related]
16. Protecting Indian schoolchildren against rabies: pre-exposure vaccination with purified chick embryo cell vaccine (PCECV) or purified verocell rabies vaccine (PVRV). Shanbag P; Shah N; Kulkarni M; Juvekar M; Madhusudana SN; Vakil HB; Malerczyk C Hum Vaccin; 2008; 4(5):365-9. PubMed ID: 18398307 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of a one week intradermal regimen for rabies post-exposure prophylaxis: results of a randomized, open label, active-controlled trial in healthy adult volunteers in India. Sudarshan MK; Narayana DH; Madhusudana SN; Holla R; Ashwin BY; Gangaboraiah B; Ravish HS Hum Vaccin Immunother; 2012 Aug; 8(8):1077-81. PubMed ID: 22699446 [TBL] [Abstract][Full Text] [Related]